Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment. The company’s main activities are focused on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor selective radionuclide treatment.
Spago Nanomedical
Spago Nanomedical is a biotechnology company with expert capabilities in contrast agent- and nanoscale life science research.
